Home › Funds › Catalio Capital Management, LP › PTGX

Catalio Capital Management, LP position in PTGX

PROTAGONIST THERAPEUTICS INC · Health Care

Catalio Capital Management, LP reported holding 106,799 shares of PTGX (PROTAGONIST THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$13.1M, representing 2.46% of its reported portfolio and ranking #16 among its reported holdings. Catalio Capital Management, LP first reported this position in Q2 2026.

Latest position (Q2 2026)106.80K sh
Reported value held$13.09M
Portfolio Weight2.46%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's PTGX position evolved

Catalio Capital Management, LP first disclosed a stake in PTGX in Q2 2026 at 106,799 shares (US$13.1M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 106.80K $13.09M New

About PTGX and 13F data

PTGX (PROTAGONIST THERAPEUTICS INC) is a Health Care company. 49 other funds we track also report a position in PTGX — the largest reported positions include Farallon Capital Management (US$778.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$778.2M), RTW INVESTMENTS, LP (US$620.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTGX

All PTGX fund holders →

FAQ

How long has Catalio Capital Management, LP held PTGX?

Catalio Capital Management, LP has disclosed PTGX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Catalio Capital Management, LP's current position in PTGX?

As of Q2 2026, Catalio Capital Management, LP holds 106.80K shares of PTGX (PROTAGONIST THERAPEUTICS INC), valued at $13.09M, representing 2.46% of its reported portfolio and ranking #16.

Has Catalio Capital Management, LP been buying or selling PTGX?

In the latest 13F filing (Q2 2026), Catalio Capital Management, LP newly opened its position in PTGX.

Which other funds hold PTGX?

Other major institutional holders of PTGX include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., RTW INVESTMENTS, LP, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.